Hjem › Prostatakreft › Mississippi
Kliniske studier for Prostatakreft i Mississippi
7 studier for Prostatakreft søker deltakere på steder i Mississippi.
Byer i Mississippi
Offisiell studietekst (engelsk)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Mississippi Medical Center, Jackson
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- Baptist Memorial Hospital and Cancer Center-Oxford, Oxford
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 19. aug. 2026 · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- University of Mississippi Medical Center, Jackson
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University of Mississippi Med Ctr, Jackson
RekruttererFase 4
Alder 18 til 100 · Menn · Oppdatert 4. jun. 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Mississippi Medical Center, Jackson
RekruttererObservasjonsstudie
Alder 21 og eldre · Menn · Oppdatert 22. mai 2026 · NCT03151629Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- University of Mississippi Medical Center, Jackson
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 22. jan. 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.